Abstract Obesity is an epidemic in the developed world. In the U.S., over one-third of women are now obese, with significant adverse consequences for their reproductive and longterm health. Many of these women gain excessive weight in pregnancy and retain it postpartum, with an additive effect across multiple pregnancies. Maternal obesity is associated with an increased risk for miscarriage, congenital anomalies, stillbirth, gestational diabetes, preeclampsia, and cesarean section. Offspring of obese women are at increased risk for being large for gestational age and may be programmed for obesity and metabolic syndrome, thus perpetuating a cycle of obesity across generations. Certain alterations to routine prenatal care may be necessary for obese women in order to optimize obstetric and neonatal outcomes. Future research priorities should be aimed at understanding the biologic mechanisms underlying the adverse outcomes associated with maternal obesity and at developing effective interventions for this growing high-risk population.
Introduction
Obesity is arguably the most pressing health concern in the developed world. Nearly 35 % of adults 20 years and older in the United States are obese [1•] . A 2005 analysis indicated that over the next several decades, there may be a sustained drop in life expectancy for Americans related to the obesity epidemic [2] . In 2011/2012, 36.1 % of women 20 years and older were obese (body mass index [BMI] ≥30 kg/m2) [1•] , with nonHispanic black women (of whom 56.6% are obese), most profoundly affected. Obesity is associated with a wide range of adverse outcomes throughout a woman's reproductive life. Obese women are at increased risk for pregnancy loss, preeclampsia, gestational diabetes (GDM), and cesarean delivery [3] [4] [5] . Offspring of obese women are at greater risk of anomalies, stillbirth, and being large for gestational age (LGA) [3, 6, 7] . Although these immediate pregnancy outcomes are of great concern, the long-term impacts of maternal obesity are potentially even worse, and are becoming increasingly apparent. Through epigenetic mechanisms, the offspring of obese women may be programmed for obesity and metabolic syndrome later in life, thereby propagating the issue across generations.
BMI is the most commonly utilized parameter to define obesity. The National Institutes of Health (NIH) and the World Health Organization (WHO) define underweight, normal weight, overweight, and obese as a BMI of <18.5, 18.5-24.9, 25.0-29.9, and ≥30 kg/m 2 , respectively. Obesity is further stratified as class I (BMI 30-34.9), class II (BMI 35-39.9) , and class III (BMI ≥40). There are obvious limitations to the use of BMI later in pregnancy, when a woman's gestational weight gain (GWG) is comprised not only of increased adipose mass but other factors, including water, amniotic fluid, placenta, and fetal weight. For this reason, studies of maternal obesity most commonly utilize a BMI calculated from a self-reported prepregnancy weight and height. Such self-reported variables are subject to bias, as women tend to underreport their pre-pregnancy weight and over-report GWG [8] . Unfortunately, even the most robust national data sources on maternal BMI and GWG, such as the Pregnancy Risk Assessment Monitoring System (PRAMS) and Pregnancy Nutrition Surveillance System (PNSS), use recalled weight values.
It is important to separate the independent effects of prepregnancy BMI and GWG on adverse pregnancy outcomes. Indeed, the relationship between GWG and adverse outcomes is modified by a woman's pre-pregnancy BMI [9, 10] . In 2009, the Institute of Medicine (IOM) released revised GWG guidelines based on pre-pregnancy BMI [11] . For obese women, the previous recommendation of GWG of at least 15 pounds was changed to a specific, fairly narrow range of 11-20 pounds. There were insufficient data to provide recommendations specifically for women in any obesity class higher than class I.
Despite the recommended 11-20 pound GWG for obese women, studies suggest that little to no GWG may be beneficial to obese women in terms of optimizing several obstetric outcomes [12, 13•] . Kominiarek et al. found that the lowest average predicted probability of composite adverse outcome (cesarean, postpartum hemorrhage, SGA, LGA, or neonatal intensive care admission) actually occurred when obese women lost weight during pregnancy [13•] . Excessive GWG is a common occurrence among all women [14] and is associated with increased risk of an LGA infant, GDM, and cesarean delivery [9, 15] . Women who gain excessive weight appear more likely to retain the weight postpartum [16] . However, the association between parity, GWG, and risk for later obesity is complex, subject to many potential confounders, and may vary with the subgroup of women studied. Cohen et al., using a life course approach, found that the prevalence of midlife (age 40-41) obesity increases with a rising number of excessive GWG events, regardless of parity [17] . Another study focusing on women in later life (66-102 years) found a doseresponse relationship between number of children and obesity [18] . After controlling for potential confounders, the risk of obesity increased 11 % with each live birth. In contrast, a recent study examining over 2,700 contemporary women in their late 20s and early 30s found that childbearing was not related to incidence of obesity [19] . It has been suggested that women who gain excessive weight during pregnancy and retain it postpartum may have gained a similar amount of weight over time, even without childbearing, related to population trends and underlying factors such as race/ethnicity, aging, and socioeconomic status [19] .
The current obesity epidemic among women, therefore, is not entirely attributable to excessive GWG and childbearing. However, a healthy diet and moderate physical activity in pregnancy should be encouraged, as observational data indicate that these factors are associated with decreased risk of excessive GWG [20] . Although some tested interventions have proven effective at helping women reduce GWG, there have been no consistently positive effects on maternal and neonatal outcomes in these studies [21] . It is also reasonable to consider referring obese women to a dietician early in pregnancy.
Retained postpartum weight has a negative impact on subsequent pregnancies. There is a linear relationship between weight retention after a first pregnancy and increased risk in subsequent pregnancies for hypertensive disorders, GDM, cesarean delivery, stillbirth, and an LGA infant [22] . Excessive GWG in the first pregnancy therefore presents a window of opportunity for intervention in terms of postpartum weight retention and subsequent pregnancies. This is particularly important as women who gain excessive weight in one pregnancy often repeat the pattern in a subsequent pregnancy [23] . Table 1 details the risk of a range of adverse pregnancy outcomes among obese women. Table 2 presents recommendations for alterations to routine prenatal care for obese women.
Fertility and Pregnancy Loss
Obesity is associated with subfertility and increased risk of pregnancy loss. This subfertility is linked to oligoovulation and polycystic ovarian syndrome, which frequently co-occur with obesity. In a prospective study of 1,651 women attempting pregnancy, there was a dose-response relationship between increasing BMI category and decreasing fecundability ratio [24] .
In a meta-analysis of studies examining the relationship between BMI and early pregnancy loss, women with a BMI ≥25 had a higher likelihood of pregnancy loss, regardless of the method of conception, with an odds ratio (OR) of 1.67 (95 % CI, 1.25-2.25), when compared to normal-weight women [4] . The association persists even for women without pregestational diabetes (a known risk factor for pregnancy loss) [4] . Although approximately two-thirds of early pregnancy losses in the general population are related to aneuploidy, there appear to be other contributing mechanisms among obese women. In a retrospective case-control study of 204 pregnancy losses, Landres et al. found a 59 % overall rate of aneuploidy, but that normal-weight women had a significantly greater number of aneuploid losses as compared to overweight and obese women (52.9 % vs. 36.6 %) of similar age (34 years) [25] .
Studies suggest that both decreased oocyte quality and decreased endometrial receptivity may contribute to pregnancy loss among obese women. The maturing oocyte and preimplantation embryo are sensitive to metabolic alterations, such as hyperinsulinemia [26] . Endometrial receptivity may be affected by the chronic inflammatory state of obesity and/or alterations in signaling of certain adipokines such as leptin and adiponectin [27] . While it is well-established that obese women undergoing IVF using autologous oocytes have decreased success (lower clinical pregnancy, lower live birth rates, and higher rates of pregnancy loss) [28] , data are conflicting regarding outcomes of IVF cycles in obese women using donor oocytes [29, 30•, 31••] . A meta-analysis concluded that obesity does not decrease the chances of pregnancy after in vitro fertilization (IVF) in donor oocyte recipients [30•] . However, a recent study, not included in that meta-analysis, among 9,587 first IVF cycles using oocyte donation from normal-weight women reported that implantation, pregnancy, clinical pregnancy, and rate of live births significantly decreased as the recipient's BMI increased, suggesting an endometrial defect [31••] .
Obese women seeking to become pregnant, either through natural or assisted reproductive methods, should be counseled regarding the range of potential adverse outcomes across gestation and encouraged to lose weight prior to pursuing pregnancy.
Congenital Anomalies
Obese women are at significantly increased -albeit low absolute -risk for a range of fetal anomalies, including neural tube defects (NTDs), cardiac anomalies, anorectal atresia, hydrocephaly, limb reduction anomalies, and cleft lip/palate [7] . These risks appear to be independent of pregestational diabetes [7] . The association between obesity and NTDs has persisted even after fortification of the U.S. grain supply with folic acid was initiated in the late 1990s [32] , and several studies have found the association between obesity and NTDs to be independent of folic acid intake in diet and/or supplements [33, 34] .
Unfortunately, although obese women are at greater risk for fetal anomalies, the ability to detect these anomalies by ultrasound is limited [35, 36] . Women must be counseled that • Provide preconception counseling at routine medical or gynecologic visits regarding the risks of obesity in pregnancy.
• Advise weight loss prior to pursuing pregnancy and discuss effective contraceptive methods. May consider referral for bariatric surgery.
Complication
Recommended management Excessive GWG
• Counsel on IOM GWG guidelines, diet and physical activity, and postpartum weight retention.
• Consider referral to a dietician.
Preeclampsia
Consider baseline 24-hour urine collection for protein in patients with chronic hypertension, renal disease ,or other risk factors for preeclampsia (i.e., pre-gestational diabetes) Gestational diabetes (GDM)
• some components of fetal anatomy may not be satisfactorily assessed at any point during gestation. However, sonographic fetal biometry is usually more accurate than fundal height measurement in women with a large abdominal panniculus.
Gestational Diabetes
Just as obesity outside of pregnancy is associated with type 2 diabetes, obesity in pregnancy increases the risk for gestational diabetes mellitus, or GDM (defined as diabetes diagnosed in pregnancy). In a study of over 16,000 women, obesity and morbid obesity were associated with odds ratios (95 % confidence interval) for GDM of 2.6 (2.1-3.4) and 4.0 (3.1-5.2), respectively. Many obese women have pregestational glucose intolerance, and some may have undiagnosed pregestational diabetes. Consideration should be given to screening obese women (and particularly those with a history of GDM) early in pregnancy for pre-existing diabetes, using fingerstick assessment of random glucose, fasting blood glucose, or hemoglobin A1c. Women who develop GDM should be counseled that they are at significant risk for developing type 2 diabetes later in life [37] and need ongoing primary care follow-up and encouragement to institute healthy lifestyle changes.
Preeclampsia
Obesity in pregnancy is also associated with an increased risk for development of preeclampsia [3] , defined by new-onset hypertension and proteinuria after 20 weeks gestation. Although this increased risk, in some cases, is related to underlying chronic hypertension and/or renal disease, obesity remains an independent risk factor [38] . Preeclampsia is associated with multiple complications, including placental abruption, preterm delivery, eclamptic seizure, and stroke. The underlying mechanisms by which obesity increases the risk for preeclampsia are not well understood. Chronic subclinical inflammation and endothelial activation may play a role. Insulin resistance may also be an important contributor to the development of preeclampsia. In a study of over 10,000 nulliparous women, a HOMA-IR (homeostasis model assessment of insulin resistance) result at ≥75th percentile was associated with nearly twice the risk (OR 1.9, 95 % CI, 1.1-3.2) of developing preeclampsia compared to a HOMA-IR result at <75th precentile [39] . The association persisted even after adjusting for BMI, race/ethnicity, treatment group, baseline blood pressure, and gestational age at sampling. Recent attention has focused on the role that dyslipidemia may play in the development of preeclampsia, and statin drugs as potential preventive agents for high-risk women. Studies using animal models indicate that statins prevent the elevation in circulating antiangiogenic factors and vascular dysfunction characteristic of preeclampsia [40, 41] . Although statins are FDA category X (risks of use in pregnancy felt to clearly outweigh potential benefits), observational data suggest that they are actually not major teratogens [42] and their use in the prevention of preeclampsia is an active area of investigation.
Similar to the relationship between GDM and type 2 diabetes, women who are preeclamptic are at increased risk to develop cardiovascular or cerebrovascular disease later in life [43•] .
Preterm Birth
When studying the relationship between obesity and preterm birth, it is important to distinguish between medically indicated (e.g., due to preeclampsia) and spontaneous (e.g., preterm labor or premature rupture of membranes) preterm birth. This is because medical conditions associated with obesity, such as chronic hypertension and diabetes, are themselves associated with increased risk for indicated preterm birth (due to concern regarding maternal and/or fetal risk of continuing the pregnancy).
In a recent analysis of nearly 1.6 million deliveries recorded in the Swedish Medical Birth Register, there was a doseresponse relationship between increasing maternal BMI and extremely preterm delivery (22-27 weeks gestation) [44••] . As compared to normal-weight women, women with a BMI of 25-30 had an adjusted OR (95 % CI) for extremely preterm delivery (indicated or spontaneous) of 1.26 (1.15-1.37). For women with a BMI >40, the OR for extremely preterm delivery was 2.99 (2.28-3.92). The risk of a medically indicated preterm birth at any gestational age increased accordingly with BMI for both overweight and obese women. When women with obesity-related disorders were excluded, the number of medically indicated preterm deliveries at 22-31 weeks was reduced by 60 %. An association between obesity and spontaneous preterm delivery was largely limited to women with higher grades of obesity and extremely preterm delivery (22-27 weeks) .
In contrast to medically indicated preterm delivery, the data have not been consistent with regard to an association between obesity and spontaneous preterm birth. Ehrenberg et al. found that among women at increased risk for spontaneous preterm birth, those with a BMI >25 were actually at decreased risk of preterm birth at 22-24 weeks (OR 0.36, 95 % CI, 0.15-0.87) compared to women with a BMI ≤25 [45] . There was a similar, although clinically insignificant, trend for preterm birth at 27-28 and 31-32 weeks.
In a secondary analysis of the Maternal-Fetal Medicine Units Network Preterm Prediction Study, obese women were found to have significantly fewer spontaneous preterm births <37 weeks (6.2 % vs. 11.2 %, p<0.001) and <34 weeks (1.5 % vs. 3.5 %, p=0.012), even after adjusting for age, parity, education, history of spontaneous preterm birth, black race, bacterial vaginosis, positive fetal fibronectin, and midtrimester cervical length [46] . Obese women also had a lower incidence of cervical length <25 mm (5 % vs. 8 %, p=0.012)
In conclusion, although obesity is consistently associated with increased risk of medically indicated preterm birth, the association between obesity and spontaneous preterm birth may be contingent on the subpopulation studied, severity of prematurity, and degree of obesity.
Sleep Apnea
Obesity is a major risk factor for obstructive sleep apnea. In the general adult population, sleep apnea is associated with increased mortality, cardiovascular disease, and stroke [47] [48] [49] . Emerging evidence suggests that sleep apnea may be an important contributor to adverse pregnancy outcomes, including pregnancy-induced hypertension, gestational diabetes, and impaired fetal growth [50, 51•] . However, the study of sleep apnea in pregnancy has been challenging, in part because the sleep apnea screening tools commonly used in non-pregnant patients are not necessarily accurate for use in pregnancy [52] .
The presence of sleep apnea may be an additional complicating factor when administering anesthesia to obese women. Obese women are already at greater risk of epidural/spinal block failure or multiple placement attempts and difficult intubation if general anesthesia is required [53] . Certain obese women at highest risk may benefit from antenatal anesthesia consultation.
Peripartum Risks
Obese women are at greater risk for a myriad of complications surrounding delivery, including cesarean delivery, oxytocin augmentation, postpartum hemorrhage, and post-term pregnancy [5, [54] [55] [56] [57] [58] [59] [60] . Multiple studies confirm a dose-response relationship between BMI and risk for cesarean delivery, particularly for the indication of "failure to progress" [56, 57, 61] . In one study, for each 1 kg/m 2 increase in maternal BMI, the risk for cesarean in labor increased by 5 % for both nulliparous and multiparous women with no prior cesarean [62••] . Progress for obese women appears to be particularly slow during the latent phase of the first stage of labor [63] . The Consortium on Safe Labor constructed modern labor curves for nearly 119,000 women with term singleton gestations and found no apparent inflection point for nulliparous women entering the active phase of labor, but women with a BMI >40 took 1.2 hours longer to reach 10 cm dilation than those with a BMI <25 [64••] . For multiparous patients, there was an inflection point around 6 cm, but it took 3.4 hours for women with a BMI ≥40 to reach 6 cm, as compared to 2.4 hours for those with a BMI <25. Obese women are also much less likely to succeed at a trial of labor after cesarean delivery. In one study, obese women with one prior cesarean had a trial-of-labor success rate of 68 %, compared to 79.6 % for non-obese women [65] .
The underlying mechanisms contributing to these labor abnormalities are not well understood, but myometrial contractility has been proposed as a potential cause. One study found that contractions were less forceful and frequent in myometrial strips obtained from obese women at the time of cesarean section compared to those from normal-weight women [66] . However, a later study did not confirm these findings [67] . Chiossi et al. reported that BMI does not affect the in vitro response of myometrial contractility to tocolytics [68] . However, other in vitro studies noted that myometrial contractility was impaired by LDL cholesterol and the adipokines apelin [69] and leptin [70] .
Clinically, the objective assessment of uterine contraction strength is performed with intrauterine pressure catheters and the calculation of Montevideo units. Two studies found no difference between obese and normal-weight women in terms of Montevideo units achieved in labor [71, 72] . Therefore, while multiple studies have confirmed that obese women are at increased risk for a prolonged first stage of labor, this may be related not to impaired strength of uterine contractions, but rather difficulty in the contractions translating to cervical change.
Unfortunately, not only are obese women more likely to require cesarean delivery, but they are also at greater risk for wound infection, longer operative time, endometritis, and excessive blood loss when compared to normal-weight women [73, 74] . Obesity compounds the risk of venous thromboembolism associated with pregnancy and the postoperative state. Although there are insufficient high-quality data to guide recommendations for thromboprophylaxis after cesarean delivery, in accordance with American College of Chest Physicians (ACCP) recommendations [75] , consideration should be given to pharmacologic thromboprophylaxis for women with more than two additional risk factors for thromboembolism, which includes obesity.
It remains controversial as to whether a transverse or vertical skin incision is superior for obese women [76, 77] . No randomized trials of skin incision types have been conducted in obese women. The delivering provider should be aware that surgical landmarks such as the umbilicus may be significantly displaced in obese women, and choice of incision may affect both the type of uterine incision and ease of delivery.
Bariatric Surgery
The number of bariatric surgeries (malabsorptive and restrictive) performed in the U.S. has risen dramatically over the last several decades. More than 80 % of bariatric surgeries are performed on women, half of whom are of reproductive age [78] . Ideally, women should delay pregnancy for 12 months after bariatric surgery (the period of most rapid weight loss). Women who have previously been oligo-ovulatory related to their obesity often begin to ovulate more regularly as they lose weight. Providers should be proactive in preparing women for this change in fertility and should recommend effective contraceptive methods for at least 12 months post-surgery.
Studies indicate that bariatric surgery is associated with decreased risk of GDM, preeclampsia, and LGA infants [79•, 80-82] , but an increased risk of anemia and SGA infants [79•, 82, 83] . Certain alterations to routine prenatal care are required for pregnant women with a history of bariatric surgery. They should be assessed regularly for nutritional deficiencies (vitamin B12, folic acid, iron, vitamin D, and calcium) and supplemented as indicated. Women who have undergone a malabsorptive procedure may have "dumping syndrome." For these women, the 50 gm glucose screen for GDM may cause fluid accumulation in the small intestine, with nausea, vomiting, diarrhea, and cramping. An alternative screening method recommended by the American Congress of Obstetrics and Gynecology is to have these women record fasting and postprandial fingerstick blood glucose for one week in both the second and third trimesters [84] . Additionally, ultrasonographic assessment of fetal growth in the third trimester in women who have had bariatric surgery is reasonable given the higher risk for SGA infants.
Clinicians should be attentive to gastrointestinal complaints and abdominal pain in pregnant women who have undergone bariatric surgery due to reported serious complications such as bowel obstruction, anastomotic leaks, hernias, and gastric rupture or band migration [85] [86] [87] . Women with gastric banding may require removal of fluid from the band to relieve nausea and vomiting or to achieve adequate nutritional intake. In such cases, consultation with a bariatric surgeon is indicated.
Stillbirth
Maternal obesity is a significant risk factor for stillbirth (defined as intrauterine fetal demise after 20 weeks gestation), particularly at later gestational ages [6, 54, 88] . A study from the Danish National Birth Cohort found that a BMI ≥30 was associated with a hazard ratio for fetal death of 3.5 (95 % CI, 1.9-6.4) at 37-39 weeks and 4.6 (95 % CI, 1.6-13.4) at >40 weeks, as compared to normal-weight women [6] . A recent analysis from the Stillbirth Collaborative Research Network including 614 stillbirth cases and 1,816 live birth controls found that overweight/obese status was independently associated with stillbirth, with an adjusted OR of 1.72 (95 % CI, 1.22-2.43) [89••] . The mechanisms by which obesity increases the risk for stillbirth are unknown, as the risk persists even after adjusting for confounding factors such as diabetes and preeclampsia [6] . Placental pathology and dysfunction may be important contributors. Obesity is associated with increased placental macrophage accumulation and inflammation [90•, 91] . Data indicate that placental monocytes are of a maternal rather than fetal genotype [92] , suggesting that such placental inflammation may be similar to the inflammation of visceral adipose tissue, an important contributor to metabolic syndrome and cardiovascular disease. In a recent study utilizing a primate model, Japanese macaques who were fed a high-calorie, high-fat diet during pregnancy had significant reduction in uterine volume blood flow, increased placental inflammation and infarctions, and associated higher number of stillbirths [93•] .
Assessment of Fetal Well-being
Given the increased risk for stillbirth, maternal obesity has been proposed as an indication to increase antenatal fetal surveillance, for example, with non-stress tests and assessments of amniotic fluid volume in the third trimester. Indeed, the increased risk for stillbirth associated with obesity is similar to many other risk factors (such as hypertension and diabetes) that are generally accepted as indications for antenatal testing [89••] . Unfortunately, as with most accepted indications for antenatal testing, it remains unproven as to whether such fetal monitoring improves outcomes among obese women [94] . With such a substantial proportion of pregnant women now who are obese, routine testing would consume significant health care resources. With no proven benefit of testing, further risk stratification of obese women based on comorbidities, age, and BMI may be a more prudent approach.
Long-term Outcomes for Offspring
Although a child's external environment certainly plays an important role in determining the risk for obesity and type 2 diabetes, the in utero environment is increasingly understood as critical in establishing the risk for childhood and adult disease. "Fetal programming" occurs through epigenetic mechanisms, or heritable changes in gene expression that occur independently of changes in the nucleotide sequence. Epigenetic mechanisms, which include chromatin remodeling and DNA methylation, may be heritable across generations [95, 96] . Early work established intrauterine growth restriction as a risk factor for obesity, metabolic syndrome, type 2 diabetes, and coronary artery disease [97] . Multiple studies have now demonstrated that LGA offspring of obese women and women with gestational and/or type 2 diabetes are also more likely to suffer from these disorders [98] [99] [100] . In a longitudinal cohort study of children at age 6, 7, 9, or 11 years, Boney et al. found that those who were born LGA to a mother with GDM were at significantly increased risk of metabolic syndrome [98] . The prevalence of at least two components of metabolic syndrome at any of the follow-up time points was 50 % for LGA/GDM children as compared to 29 % for the LGA/non-diabetic group, 21 % for the appropriate-for-gestational age (AGA)/GDM group, and 18 % for the AGA/non-diabetic group. Highlighting the perpetuation of the intergenerational cycle of obesity, a recent study from the Swedish Medical Birth Register demonstrated that women born LGA are more likely to be obese and that their risk of having an LGA offspring themselves increases with their BMI [101•] . The impact of maternal obesity on offspring may not be limited to a long-term risk for obesity and metabolic syndrome. Recent data suggest that maternal obesity may increase the risk for neurodevelopment problems in offspring [102••, 103] . In a case-control study, maternal metabolic conditions (including diabetes and obesity) increased the risk for autism in children 2-5 years of age (OR 1.61, 95 % CI, 1.10-2.37) [102••] .
Conclusion
More than one-third of women are obese and at risk for a wide range of adverse outcomes throughout each pregnancy and across their reproductive lives and beyond. The offspring of obese women are at risk for outcomes such as LGA, which carries the potential for lifelong adverse health consequences and a propagation of risk across generations. Women who develop preeclampsia and gestational diabetes should be counseled that they are at increased long-term risk for cardiovascular disease and type 2 diabetes, respectively [37, 43•] . The development of these conditions in obese women represents a window into their future health and a "teachable moment" with regard to preventive measures. Clinicians should seize the opportunity to counsel and motivate women with regard to postpartum weight loss and lifestyle modifications that will improve outcomes not only for any future pregnancies, but for themselves and their offspring across their lifespans. Future research should focus on understanding the biological underpinnings of established epidemiological associations such that the most targeted and effective interventions may be implemented for obese women who are pregnant or contemplating pregnancy.
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